DK2442799T3 - Fast farmaceutisk sammensætning omfattende rivaroxaban - Google Patents
Fast farmaceutisk sammensætning omfattende rivaroxabanInfo
- Publication number
- DK2442799T3 DK2442799T3 DK10725746.1T DK10725746T DK2442799T3 DK 2442799 T3 DK2442799 T3 DK 2442799T3 DK 10725746 T DK10725746 T DK 10725746T DK 2442799 T3 DK2442799 T3 DK 2442799T3
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceutical composition
- composition including
- fixed pharmaceutical
- rivaroxaban
- including rivaroxaban
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09163177A EP2266541A1 (en) | 2009-06-18 | 2009-06-18 | Solid pharmaceutical composition comprising rivaroxaban |
EP10156445 | 2010-03-12 | ||
PCT/EP2010/058680 WO2010146179A2 (en) | 2009-06-18 | 2010-06-18 | Solid pharmaceutical composition comprising rivaroxaban |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2442799T3 true DK2442799T3 (da) | 2017-01-02 |
Family
ID=42352709
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK10725746.1T DK2442799T3 (da) | 2009-06-18 | 2010-06-18 | Fast farmaceutisk sammensætning omfattende rivaroxaban |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP2442799B2 (da) |
DK (1) | DK2442799T3 (da) |
EA (1) | EA035562B1 (da) |
ES (1) | ES2606127T5 (da) |
HR (1) | HRP20161617T4 (da) |
HU (1) | HUE031177T2 (da) |
LT (1) | LT2442799T (da) |
PL (1) | PL2442799T5 (da) |
PT (1) | PT2442799T (da) |
SI (1) | SI2442799T2 (da) |
WO (1) | WO2010146179A2 (da) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130064888A1 (en) | 2011-08-08 | 2013-03-14 | Roey Solomonovich | Pharmaceutical formulations |
SI2935255T1 (en) | 2012-12-21 | 2018-01-31 | Farma Grs, D. O. O. | PROCEDURE FOR PREPARATION OF RIVAROKSABAN |
EP2808011A1 (en) * | 2013-05-29 | 2014-12-03 | Sandoz Ag | Process for the preparation of a pharmaceutical composition comprising Rivaroxaban |
AU2014372692A1 (en) * | 2013-12-23 | 2016-07-14 | Laboratorios Del Dr. Esteve, S.A. | Oral pharmaceutical composition |
WO2015124995A1 (en) | 2014-02-19 | 2015-08-27 | Aurobindo Pharma Ltd | Solid dosage forms of rivaroxaban |
CN104055743B (zh) * | 2014-06-10 | 2016-01-06 | 吉林省博大制药有限责任公司 | 一种含利伐沙班口服制剂的制备方法 |
TR201501970A2 (en) * | 2015-02-19 | 2016-09-21 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Pharmaceutical combinations of dronedarone. |
WO2016144071A2 (ko) * | 2015-03-06 | 2016-09-15 | 에스케이케미칼 주식회사 | 리바록사반을 포함하는 약학제제 |
WO2016166733A1 (en) * | 2015-04-17 | 2016-10-20 | Micro Labs Limited | A process for preparing a pharmaceutical composition comprising rivaroxaban |
EP3331503A1 (en) * | 2015-08-05 | 2018-06-13 | Interquim, S.A. | Rivaroxaban pharmaceutical compositions |
CN105078915A (zh) * | 2015-08-27 | 2015-11-25 | 江苏中邦制药有限公司 | 一种利伐沙班片及其制备方法 |
EP3419603A4 (en) * | 2016-02-25 | 2019-11-13 | Mylan Inc. | UNIQUE GRANULATION PROCESS WITH HIGH SHARK FOR IMPROVED BIOAVAILABILITY OF RIVAROXABAN |
EP3263096A1 (en) * | 2016-06-28 | 2018-01-03 | Sanovel Ilac Sanayi ve Ticaret A.S. | Pharmaceutical capsule composition of rivaroxaban |
BR112019000187A2 (pt) * | 2016-07-05 | 2019-04-24 | Alphamed Formulations Pvt Ltd | composição sólida contendo anticoagulante oral |
EP4257136A3 (en) | 2017-12-31 | 2023-11-29 | Abdi Ibrahim Ilac Sanayi ve Ticaret A.S. | Preparation of a solid pharmaceutical composition comprising rivaroxaban and production thereof |
GR1009619B (el) * | 2018-05-09 | 2019-10-23 | Φαρμαζακ Α.Φ.Ε.Β.Ε. | Φαρμακευτικη συνθεση που περιεχει ριβαροξαβανη και μεθοδος για την παρασκευη αυτης |
EP3796915A4 (en) * | 2018-11-16 | 2022-01-26 | Santa Farma Ilaç Sanayi A.S. | ORAL FORMULATIONS CONTAINING RIVAROXABAN |
EP4208462A1 (en) * | 2020-09-05 | 2023-07-12 | Inventia Healthcare Limited | Rivaroxaban compositions |
WO2022259118A1 (en) * | 2021-06-10 | 2022-12-15 | Shilpa Medicare Limited | Fast dissolving oral film preparation comprising rivaroxaban |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19962924A1 (de) | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
DE10355461A1 (de) * | 2003-11-27 | 2005-06-23 | Bayer Healthcare Ag | Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung |
DE102004062475A1 (de) * | 2004-12-24 | 2006-07-06 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung |
DE102005047561A1 (de) | 2005-10-04 | 2007-04-05 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung |
US8188270B2 (en) | 2005-10-04 | 2012-05-29 | Bayer Schering Pharma Aktiengesellschaft | Polymorphous form of 5-chloro-N-({(5S)-2-oxo-3[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide |
DE102007048705A1 (de) | 2007-10-11 | 2009-04-16 | Bayer Healthcare Ag | Amorphe Formulierung |
WO2010003641A1 (en) * | 2008-07-08 | 2010-01-14 | Ratiopharm Gmbh | Pharmaceutical compositions comprising 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid |
CA2733611A1 (en) * | 2008-08-11 | 2010-02-18 | Ratiopharm Gmbh | Pharmaceutical compositions with modified release properties comprising 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid |
-
2010
- 2010-06-18 WO PCT/EP2010/058680 patent/WO2010146179A2/en active Application Filing
- 2010-06-18 PL PL10725746T patent/PL2442799T5/pl unknown
- 2010-06-18 DK DK10725746.1T patent/DK2442799T3/da active
- 2010-06-18 SI SI201031344T patent/SI2442799T2/sl unknown
- 2010-06-18 ES ES10725746T patent/ES2606127T5/es active Active
- 2010-06-18 EA EA201190319A patent/EA035562B1/ru not_active IP Right Cessation
- 2010-06-18 EP EP10725746.1A patent/EP2442799B2/en active Active
- 2010-06-18 LT LTEP10725746.1T patent/LT2442799T/lt unknown
- 2010-06-18 HU HUE10725746A patent/HUE031177T2/hu unknown
- 2010-06-18 PT PT107257461T patent/PT2442799T/pt unknown
-
2016
- 2016-12-01 HR HRP20161617TT patent/HRP20161617T4/hr unknown
Also Published As
Publication number | Publication date |
---|---|
WO2010146179A3 (en) | 2011-04-14 |
EP2442799B1 (en) | 2016-09-07 |
WO2010146179A2 (en) | 2010-12-23 |
PL2442799T5 (pl) | 2019-09-30 |
EP2442799A2 (en) | 2012-04-25 |
SI2442799T1 (sl) | 2017-02-28 |
ES2606127T3 (es) | 2017-03-22 |
HUE031177T2 (hu) | 2017-07-28 |
EA201190319A1 (ru) | 2012-06-29 |
HRP20161617T1 (hr) | 2017-01-13 |
PT2442799T (pt) | 2016-12-07 |
HRP20161617T4 (hr) | 2019-06-28 |
EA035562B1 (ru) | 2020-07-08 |
LT2442799T (lt) | 2016-12-27 |
ES2606127T5 (es) | 2020-02-17 |
PL2442799T3 (pl) | 2017-04-28 |
EP2442799B2 (en) | 2019-05-22 |
SI2442799T2 (sl) | 2019-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2442799T3 (da) | Fast farmaceutisk sammensætning omfattende rivaroxaban | |
SMT201700095B (is) | Composizioni farmaceutiche per inalazione | |
SMT201700008B (it) | Composizione farmaceutica | |
DK3097925T3 (da) | Farmaceutisk sammensætning | |
BRPI1004940A2 (pt) | composição farmacêutica | |
SMT201600307B (it) | Composizione liposomiale | |
BRPI1015939A2 (pt) | composição farmacêutica | |
BR112012012108A2 (pt) | composição farmacêutica compreendendo propofol | |
DK3246018T3 (da) | Farmaceutisk sammensætning | |
BRPI1013588A2 (pt) | composição | |
BRPI1012539A2 (pt) | composições farmacêuticas | |
BRPI1015474A2 (pt) | composição | |
DK2459221T3 (da) | Farmaceutisk formulering | |
EE201300005A (et) | Ravimkoostis | |
DK2285413T3 (da) | Farmaceutisk sammensætning | |
IT1394400B1 (it) | Composizioni farmaceutiche | |
DK2654736T3 (da) | Hidtil ukendt farmaceutisk sammensætning | |
DK2391349T3 (da) | Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater | |
BR112012000831A2 (pt) | compostos, composições farmacêuticas e métodos relacionados | |
BRPI0921313A2 (pt) | composição farmaucêutica | |
DK2391351T3 (da) | Farmaceutisk sammensætning omfattende 2-oxo-1-pyrrolidinderivater | |
BR112012003149A2 (pt) | composição farmacêutica | |
BR112012001340A2 (pt) | composições farmacêuticas | |
BRPI0912171A2 (pt) | composição farmacêutica | |
BRPI1005290A2 (pt) | composição |